Last edition
News about "Valneva "
Valneva and Serum Institute End Chikungunya Vaccine Licensing Deal
Valneva SE and the Serum Institute of India have mutually agreed to discontinue their licensing agreement for Valneva’s single-shot chikungunya vaccine, bringing the collaboration to a close by mutual consent.
Valneva | 01/01/2026 | By News Bureau
Valneva to Further Consolidate its Operations in France
The move is part of Valneva’s strategy to optimise its global footprint, enhance operational efficiency in France, and unify all research and development efforts at its Vienna hub.
Valneva | 28/11/2025 | By Dineshwori | 179
Valneva Names Dr. Hanneke Schuitemaker as Chief Scientific Officer
Valneva has appointed Dr. Hanneke Schuitemaker, PhD as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024.
Valneva | 22/05/2024 | By Aishwarya | 428
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy